<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38961383</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1479-5876</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>03</Day></PubDate></JournalIssue><Title>Journal of translational medicine</Title><ISOAbbreviation>J Transl Med</ISOAbbreviation></Journal><ArticleTitle>Targeted metabolomics identifies accurate CSF metabolite biomarkers for the differentiation between COVID-19 with neurological involvement and CNS infections with neurotropic viral pathogens.</ArticleTitle><Pagination><StartPage>620</StartPage><MedlinePgn>620</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">620</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12967-024-05422-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">COVID-19 is primarily considered a respiratory tract infection, but it can also affect the central nervous system (CNS), which can result in long-term sequelae. In contrast to CNS infections by classic neurotropic viruses, SARS-CoV-2 is usually not detected in cerebrospinal fluid (CSF) from patients with COVID-19 with neurological involvement (neuro-COVID), suggesting fundamental differences in pathogenesis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">To assess differences in CNS metabolism in neuro-COVID compared to CNS infections with classic neurotropic viruses, we applied a targeted metabolomic analysis of 630 metabolites to CSF from patients with (i) COVID-19 with neurological involvement [n&#x2009;=&#x2009;16, comprising acute (n&#x2009;=&#x2009;13) and post-COVID-19 (n&#x2009;=&#x2009;3)], (ii) viral meningitis, encephalitis, or myelitis (n&#x2009;=&#x2009;10) due to herpes simplex virus (n&#x2009;=&#x2009;2), varicella zoster virus (n&#x2009;=&#x2009;6), enterovirus (n&#x2009;=&#x2009;1) and tick-borne encephalitis virus (n&#x2009;=&#x2009;1), and (iii) aseptic neuroinflammation (meningitis, encephalitis, or myelitis) of unknown etiology (n&#x2009;=&#x2009;21) as additional disease controls.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Standard CSF parameters indicated absent or low neuroinflammation in neuro-COVID. Indeed, CSF cell count was low in neuro-COVID (median 1 cell/&#xb5;L, range 0-12) and discriminated it accurately from viral CNS infections (AUC&#x2009;=&#x2009;0.99) and aseptic neuroinflammation (AUC&#x2009;=&#x2009;0.98). 32 CSF metabolites passed quality assessment and were included in the analysis. Concentrations of differentially abundant (fold change&#x2009;&#x2265;|1.5|, FDR&#x2009;&#x2264;&#x2009;0.05) metabolites were both higher (9 and 5 metabolites) and lower (2 metabolites) in neuro-COVID than in the other two groups. Concentrations of citrulline, ceramide (d18:1/18:0), and methionine were most significantly elevated in neuro-COVID. Remarkably, triglyceride TG(20:1_32:3) was much lower (mean fold change&#x2009;=&#x2009;0.09 and 0.11) in neuro-COVID than in all viral CNS infections and most aseptic neuroinflammation samples, identifying it as highly accurate biomarker with AUC&#x2009;=&#x2009;1 and 0.93, respectively. Across all samples, TG(20:1_32:3) concentration correlated only moderately with CSF cell count (&#x3c1;&#x2009;=&#x2009;0.65), protein concentration (&#x3c1;&#x2009;=&#x2009;0.64), and Q-albumin (&#x3c1;&#x2009;=&#x2009;0.48), suggesting that its low levels in neuro-COVID CSF are only partially explained by less pronounced neuroinflammation.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The results suggest that CNS metabolite responses in neuro-COVID differ fundamentally from viral CNS infections and aseptic neuroinflammation and may be used to discover accurate diagnostic biomarkers in CSF and to gain insights into differences in pathophysiology between neuro-COVID, viral CNS infections and aseptic neuroinflammation.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Neu</LastName><ForeName>Frieder</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Research Group Biomarkers for Infectious Diseases, TWINCORE Centre for Experimental and Clinical Infection Research, Feodor-Lynen-Str. 7, 30625, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Study Programme Medicine, Riga Stradins University, Riga, Latvia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nay</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuchardt</LastName><ForeName>Sven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klawonn</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Biostatistics, Helmholtz Centre for Infection Research, Brunswick, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skripuletz</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Suehs</LastName><ForeName>Kurt-Wolfram</ForeName><Initials>KW</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Pessler</LastName><ForeName>Frank</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-3434-2311</Identifier><AffiliationInfo><Affiliation>Research Group Biomarkers for Infectious Diseases, TWINCORE Centre for Experimental and Clinical Infection Research, Feodor-Lynen-Str. 7, 30625, Hannover, Germany. frank.pessler@helmholtz-hzi.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Individualised Infection Medicine, Hannover, Germany. frank.pessler@helmholtz-hzi.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Group Biomarkers for Infectious Diseases, Helmholtz Centre for Infection Research, Brunswick, Germany. frank.pessler@helmholtz-hzi.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Transl Med</MedlineTA><NlmUniqueID>101190741</NlmUniqueID><ISSNLinking>1479-5876</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="Y">Biomarkers</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055432" MajorTopicYN="Y">Metabolomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002494" MajorTopicYN="N">Central Nervous System Infections</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biomarker</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Ceramides</Keyword><Keyword MajorTopicYN="N">Cerebrospinal fluid</Keyword><Keyword MajorTopicYN="N">Diagnosis</Keyword><Keyword MajorTopicYN="N">Encephalitis</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Meningitis</Keyword><Keyword MajorTopicYN="N">Metabolism</Keyword><Keyword MajorTopicYN="N">Neuroinflammation</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Triglycerides</Keyword></KeywordList><CoiStatement>None of the authors have a competing interest relating to conduct of the study or publication of the manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>4</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>3</Day><Hour>23</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38961383</ArticleId><ArticleId IdType="pmc">PMC11223383</ArticleId><ArticleId IdType="doi">10.1186/s12967-024-05422-1</ArticleId><ArticleId IdType="pii">10.1186/s12967-024-05422-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mallah SI, Ghorab OK, Al-Salmi S, Abdellatif OS, Tharmaratnam T, Iskandar MA, et al. COVID-19: breaking down a global health crisis. Ann Clin Microbiol Antimicrob. 2021;20(1):35. doi: 10.1186/s12941-021-00438-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12941-021-00438-7</ArticleId><ArticleId IdType="pmc">PMC8129964</ArticleId><ArticleId IdType="pubmed">34006330</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai AD, Lavelle M, Boursiquot BC, Wan EY. Long-term complications of COVID-19. Am J Physiol Cell Physiol. 2022;322(1):C1&#x2013;c11. doi: 10.1152/ajpcell.00375.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00375.2021</ArticleId><ArticleId IdType="pmc">PMC8721906</ArticleId><ArticleId IdType="pubmed">34817268</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyah Y, Benjelloun M, Lairini S, Lahrichi A. COVID-19 impact on public health, environment, human psychology, global socioeconomy, and education. Sci World J. 2022;2022:5578284. doi: 10.1155/2022/5578284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/5578284</ArticleId><ArticleId IdType="pmc">PMC8767375</ArticleId><ArticleId IdType="pubmed">35069037</ArticleId></ArticleIdList></Reference><Reference><Citation>Harapan BN, Yoo HJ. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) J Neurol. 2021;268(9):3059&#x2013;3071. doi: 10.1007/s00415-021-10406-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10406-y</ArticleId><ArticleId IdType="pmc">PMC7826147</ArticleId><ArticleId IdType="pubmed">33486564</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19(9):767&#x2013;783. doi: 10.1016/S1474-4422(20)30221-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30221-0</ArticleId><ArticleId IdType="pmc">PMC7332267</ArticleId><ArticleId IdType="pubmed">32622375</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683&#x2013;690. doi: 10.1001/jamaneurol.2020.1127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55&#x2013;58. doi: 10.1016/j.ijid.2020.03.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.03.062</ArticleId><ArticleId IdType="pmc">PMC7195378</ArticleId><ArticleId IdType="pubmed">32251791</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarius S, Pache F, K&#xf6;rtvelyessy P, Jel&#x10d;i&#x107; I, Stettner M, Franciotta D, et al. Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients. J Neuroinflamm. 2022;19(1):19. doi: 10.1186/s12974-021-02339-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02339-0</ArticleId><ArticleId IdType="pmc">PMC8771621</ArticleId><ArticleId IdType="pubmed">35057809</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382:2268&#x2013;70. doi: 10.1056/NEJMc2008597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2008597</ArticleId><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilotto A, Odolini S, Masciocchi S, Comelli A, Volonghi I, Gazzina S, et al. Steroid-responsive encephalitis in coronavirus disease 2019. Ann Neurol. 2020;88(2):423&#x2013;427. doi: 10.1002/ana.25783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25783</ArticleId><ArticleId IdType="pmc">PMC7276848</ArticleId><ArticleId IdType="pubmed">32418288</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Zhang Z, Zhou J, Han S, Kang Z, Chuang H, et al. Next-generation sequencing and proteomics of cerebrospinal fluid from COVID-19 patients with neurological manifestations. Front Immunol. 2021;12:782731. doi: 10.3389/fimmu.2021.782731.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.782731</ArticleId><ArticleId IdType="pmc">PMC8695435</ArticleId><ArticleId IdType="pubmed">34956212</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Mekhlafi A, Suhs KW, Schuchardt S, Kuhn M, Muller-Vahl K, Trebst C, et al. Elevated free phosphatidylcholine levels in cerebrospinal fluid distinguish bacterial from viral CNS infections. Cells. 2021;10(5):1115. doi: 10.3390/cells10051115.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10051115</ArticleId><ArticleId IdType="pmc">PMC8148106</ArticleId><ArticleId IdType="pubmed">34066349</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratuszny D, Suhs KW, Novoselova N, Kuhn M, Kaever V, Skripuletz T, et al. Identification of cerebrospinal fluid metabolites as biomarkers for enterovirus meningitis. Int J Mol Sci. 2019;20(2):337. doi: 10.3390/ijms20020337.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20020337</ArticleId><ArticleId IdType="pmc">PMC6359617</ArticleId><ArticleId IdType="pubmed">30650575</ArticleId></ArticleIdList></Reference><Reference><Citation>Suhs KW, Novoselova N, Kuhn M, Seegers L, Kaever V, Muller-Vahl K, et al. Kynurenine is a cerebrospinal fluid biomarker for bacterial and viral central nervous system infections. J Infect Dis. 2019;220(1):127&#x2013;138. doi: 10.1093/infdis/jiz048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiz048</ArticleId><ArticleId IdType="pubmed">30721966</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn M, Suhs KW, Akmatov MK, Klawonn F, Wang J, Skripuletz T, et al. Mass-spectrometric profiling of cerebrospinal fluid reveals metabolite biomarkers for CNS involvement in varicella zoster virus reactivation. J Neuroinflamm. 2018;15(1):20. doi: 10.1186/s12974-017-1041-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-017-1041-0</ArticleId><ArticleId IdType="pmc">PMC5773076</ArticleId><ArticleId IdType="pubmed">29343258</ArticleId></ArticleIdList></Reference><Reference><Citation>de Araujo LS, Pessler K, Suhs KW, Novoselova N, Klawonn F, Kuhn M, et al. Phosphatidylcholine PC ae C44:6 in cerebrospinal fluid is a sensitive biomarker for bacterial meningitis. J Transl Med. 2020;18(1):9. doi: 10.1186/s12967-019-02179-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-019-02179-w</ArticleId><ArticleId IdType="pmc">PMC6945415</ArticleId><ArticleId IdType="pubmed">31910875</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y, M&#xf6;hn N, Al-Mekhlafi A, Schuchardt S, Skripuletz T, S&#xfc;hs W, et al. Targeted metabolomic profiling of cerebrospinal fluid from patients with progressive multifocal leukoencephalopathy. PLoS ONE. 2020;15(11):e0242321. doi: 10.1371/journal.pone.0242321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0242321</ArticleId><ArticleId IdType="pmc">PMC7685473</ArticleId><ArticleId IdType="pubmed">33232337</ArticleId></ArticleIdList></Reference><Reference><Citation>Westman G, Aurelius E, Ahlm C, Blennow K, Eriksson K, Lind L, et al. Cerebrospinal fluid biomarkers of brain injury, inflammation and synaptic autoimmunity predict long-term neurocognitive outcome in herpes simplex encephalitis. Clin Microbiol Infect. 2021;27(8):1131&#x2013;1136. doi: 10.1016/j.cmi.2020.09.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.031</ArticleId><ArticleId IdType="pubmed">32979577</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Mekhlafi A, Waqas FH, Krueger M, Klawonn F, Akmatov MK, Muller-Vahl K, et al. Elevated phospholipids and acylcarnitines C4 and C5 in cerebrospinal fluid distinguish viral CNS infections from autoimmune neuroinflammation. J Transl Med. 2023;21(1):776. doi: 10.1186/s12967-023-04637-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-023-04637-y</ArticleId><ArticleId IdType="pmc">PMC10621113</ArticleId><ArticleId IdType="pubmed">37919735</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider F, Agin A, Baldacini M, Maurer L, Schenck M, Alemann M, et al. Acute-onset delirium in intensive care COVID patients: association of imperfect brain repair with foodborne micro-pollutants. Eur J Neurol. 2021;28(10):3443&#x2013;3447. doi: 10.1111/ene.14776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14776</ArticleId><ArticleId IdType="pmc">PMC8014494</ArticleId><ArticleId IdType="pubmed">33583103</ArticleId></ArticleIdList></Reference><Reference><Citation>Putz K, Hayani K, Zar FA. Meningitis. Prim Care. 2013;40(3):707&#x2013;726. doi: 10.1016/j.pop.2013.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pop.2013.06.001</ArticleId><ArticleId IdType="pubmed">23958365</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellul M, Solomon T. Acute encephalitis&#x2014;diagnosis and management. Clin Med. 2018;18(2):155&#x2013;159. doi: 10.7861/clinmedicine.18-2-155.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmedicine.18-2-155</ArticleId><ArticleId IdType="pmc">PMC6303463</ArticleId><ArticleId IdType="pubmed">29626021</ArticleId></ArticleIdList></Reference><Reference><Citation>Irani DN. Aseptic meningitis and viral myelitis. Neurol Clin. 2008;26(3):635&#x2013;655. doi: 10.1016/j.ncl.2008.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2008.03.003</ArticleId><ArticleId IdType="pmc">PMC2728900</ArticleId><ArticleId IdType="pubmed">18657719</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiber H. Cerebrospinal fluid&#x2013;physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Mult Scler. 1998;4(3):99&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">9762655</ArticleId></ArticleIdList></Reference><Reference><Citation>IBM SPSS Missing Values 28. https://www.ibm.com/docs/en/SSLVMB_28.0.0/pdf/IBM_SPSS_Missing_Values.pdf. Accessed 31 Oct 2023.</Citation></Reference><Reference><Citation>Pang Z, Zhou G, Ewald J, Chang L, Hacariz O, Basu N, et al. Using MetaboAnalyst 5.0 for LC-HRMS spectra processing, multi-omics integration and covariate adjustment of global metabolomics data. Nat Protoc. 2022;17(8):1735&#x2013;61. doi: 10.1038/s41596-022-00710-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41596-022-00710-w</ArticleId><ArticleId IdType="pubmed">35715522</ArticleId></ArticleIdList></Reference><Reference><Citation>Novoselova N, Wang J, Pessler F, Klawonn F. Biocomb: feature selection and classification with the embedded validation procedures for biomedical data analysis. R package version 0.4. 2018. https://CRAN.R-project.org/package=Biocomb. Accessed 31 Oct 2023.</Citation></Reference><Reference><Citation>Hosmer DW, Jr, Lemeshow S, Sturdivant RX. Applied logistic regression. Hoboken: John Wiley &amp; Sons; 2013.</Citation></Reference><Reference><Citation>Buchman AL. Side effects of corticosteroid therapy. J Clin Gastroenterol. 2001;33(4):289&#x2013;294. doi: 10.1097/00004836-200110000-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00004836-200110000-00006</ArticleId><ArticleId IdType="pubmed">11588541</ArticleId></ArticleIdList></Reference><Reference><Citation>Bazinet RP, Lay&#xe9; S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat Rev Neurosci. 2014;15(12):771&#x2013;785. doi: 10.1038/nrn3820.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3820</ArticleId><ArticleId IdType="pubmed">25387473</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonteh AN, Fisher RD. Combining lipidomics and proteomics of human cerebrospinal fluids. Methods Mol Biol. 2009;579:71&#x2013;86. doi: 10.1007/978-1-60761-322-0_4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-60761-322-0_4</ArticleId><ArticleId IdType="pubmed">19763471</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis HM, Liu Y, Frampas CF, Longman K, Spick M, Stewart A, et al. Metabolomics markers of COVID-19 are dependent on collection wave. Metabolites. 2022;12(8):713. doi: 10.3390/metabo12080713.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12080713</ArticleId><ArticleId IdType="pmc">PMC9415837</ArticleId><ArticleId IdType="pubmed">36005585</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia M, Wang Y, Wang J, Qin D, Wang M, Chai L, et al. Myristic acid as a checkpoint to regulate STING-dependent autophagy and interferon responses by promoting N-myristoylation. Nat Commun. 2023;14(1):660. doi: 10.1038/s41467-023-36332-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-36332-3</ArticleId><ArticleId IdType="pmc">PMC9905541</ArticleId><ArticleId IdType="pubmed">36750575</ArticleId></ArticleIdList></Reference><Reference><Citation>Kornhuber J, Hoertel N, Gulbins E. The acid sphingomyelinase/ceramide system in COVID-19. Mol Psychiatry. 2022;27(1):307&#x2013;314. doi: 10.1038/s41380-021-01309-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-021-01309-5</ArticleId><ArticleId IdType="pmc">PMC8488928</ArticleId><ArticleId IdType="pubmed">34608263</ArticleId></ArticleIdList></Reference><Reference><Citation>Arshad H, et al. Decreased plasma phospholipid concentrations and increased acid sphingomyelinase activity are accurate biomarkers for community-acquired pneumonia. J Transl Med. 2019;17(1):365. doi: 10.1186/s12967-019-2112-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-019-2112-z</ArticleId><ArticleId IdType="pmc">PMC6849224</ArticleId><ArticleId IdType="pubmed">31711507</ArticleId></ArticleIdList></Reference><Reference><Citation>Onoja A, et al. Meta-analysis of COVID-19 metabolomics identifies variations in robustness of biomarkers. Int J Mol Sci. 2023;24(18):14371. doi: 10.3390/ijms241814371.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241814371</ArticleId><ArticleId IdType="pmc">PMC10531504</ArticleId><ArticleId IdType="pubmed">37762673</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>